Ameren (AEE)
NYSE: AEE · Multi-Utilities · St Louis, MO
Our rating: Neutral
Neutral reaffirmed at $114.02, moderate conviction, November 9, 2026.
Breaks if: The Neutral call turns Positive if Ameren reports diluted EPS of $5.80 or above on the next full-year print — roughly 8-9% growth from the current $5.35 — confirming that rate-base compounding is running faster than a 21x multiple already implies. It turns Cautious if EPS falls below $5.00 on the next annual report, or if a rate case decision from its primary state regulators produces an allowed ROE below 9.5% within the next 12 months, signaling that the regulatory compact is tightening and the premium multiple becomes harder to defend.
Key figures
| Market value | $31.0B |
|---|---|
| Revenue, last 12 months | $8.7B |
| Net income, last 12 months | $1.6B |
| Free cash flow, last 12 months | −$1.4B |
| Price to earnings | 19.8× |
| Free cash flow yield | −4.5% |
| Dividend yield | 2.6% |
| Operating margin | 24.9% |
| Return on equity | 12.1% |
| Beta to the S&P 500 | 0.11 |
| Volatility, annualized | 17.6% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| June 30, 2026 | $2.1B | −5.8% | $1.13 | −$309M |
| March 31, 2026 | $2.2B | 3.8% | $1.28 | −$1.2B |
| December 31, 2025 | $1.8B | −8.2% | $0.92 | −$54M |
| September 30, 2025 | $2.7B | 24.2% | $2.35 | $116M |
| June 30, 2025 | $2.2B | 31.2% | $1.01 | −$204M |
| March 31, 2025 | $2.1B | 15.5% | $1.07 | −$633M |
| December 31, 2024 | $1.9B | 20.0% | $0.77 | −$473M |
| September 30, 2024 | $2.2B | 5.5% | $1.70 | −$240M |
9 ledger entries and 31 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.